序号	中文	英文	操作
161	John W. Mellors, University of Pittsburgh School of Medicine, USA	John W. Mellors, University of Pittsburgh School of Medicine, USA	查看中文全文00003 查看英文全文00003
162	Ali Mirazimi, Department of Laboratory medicin, Karolinska institutet, Sweden	Ali Mirazimi, Department of Laboratory medicin, Karolinska institutet, Sweden	查看中文全文00003 查看英文全文00003
163	Kayvon Modjarrad, Walter Reed Army Institute of Research, USA	Kayvon Modjarrad, Walter Reed Army Institute of Research, USA	查看中文全文00003 查看英文全文00003
164	Stefan O. Mueller, CureVac, Germany	Stefan O. Mueller, CureVac, Germany	查看中文全文00003 查看英文全文00003
165	Vincent J. Munster, National Institutes of Health, U.S. Department of Health and Human Services, USA	Vincent J. Munster, National Institutes of Health, U.S. Department of Health and Human Services, USA	查看中文全文00003 查看英文全文00003
166	César Muñoz-Fontela, Bernhard-Nocht-Institute for Tropical Medicine, Germany	César Muñoz-Fontela, Bernhard-Nocht-Institute for Tropical Medicine, Germany	查看中文全文00003 查看英文全文00003
167	Aysegul Nalca, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), USA	Aysegul Nalca, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), USA	查看中文全文00003 查看英文全文00003
168	José Manuel Ochoa, Altimmune Inc., USA	José Manuel Ochoa, Altimmune Inc., USA	查看中文全文00003 查看英文全文00003
169	Dave O'Connor, University of Wisconsin-Madison, USA	Dave O'Connor, University of Wisconsin-Madison, USA	查看中文全文00003 查看英文全文00003
170	Lidia Oostvogels, CureVac, Germany	Lidia Oostvogels, CureVac, Germany	查看中文全文00003 查看英文全文00003